Lotilaner
Ectoparasite control in dogs and cats; ophthalmic use for demodex blepharitis
- CAS No.
- 1369852-71-0
- Indication Class
- Animal Health
- Patent Expiry
- To be assessed
- Therapeutic Area
- Animal Health / Ophthalmology
- Labeled Purity
- 98%+
- Registration Readiness
- GMP/DMF
- Commercialization Tier
- API (Commercialized)
- Linked Intermediates
- 3 key intermediates available
Key Intermediates for This API
Order: listed intermediates that accept enquiries first; fragments shared across several APIs rank higher| Intermediate | CAS | Shared | Action |
|---|---|---|---|
| 2-bromo-3-methyl-5-acetylthiophene | 859199-06-7 | — | |
| 5-acetyl-3-methyl-2-Thiophenecarboxylic acid | 2758907-91-2 | — | |
| methyl 5-acetyl-3-methylthiophene-2-carboxylate | 2758907-87-6 | — |
Listing Logic · Why It's Worth Listing
The only isoxazoline expanded into human ophthalmology (demodex blepharitis), combining a steady animal-health base with a human-use upside option.
Animal Health / Ophthalmology · Marketed; available for immediate sourcing
GMP/DMF-ready; supports regulatory filing and audit in target markets
3 key intermediates available; scale-up and cost control manageable
Product Description
Lotilaner is an ectoparasiticide from the modern isoxazoline class, notable for its unique dual utility. While established in veterinary medicine, it has achieved a groundbreaking milestone as the first FDA-approved drug for a specific human eye condition.
Supply source: Unibest · Lotilaner, sourced, vetted and delivered by Unibest. Therapeutic area, indication and listing rationale are qualitative summaries based on public drug knowledge for business reference; actual registration availability and quality specifications are subject to DMF/GMP documentation and the technical agreement confirmed at order.